Drug use in a geriatric long-term care setting: comparison between newly admitted and institutionalised patients

Drugs & Aging
Zeev ArinzonYitshal N Berner

Abstract

Advanced age, co-morbid diseases, functional dependence and frailty are associated with polypharmacy and overall high health expenditures. Polypharmacy is commonly defined as the concomitant ingestion of four or more medications, particularly in community-dwelling patients, but the number of drugs being taken by institutionalised and hospitalised patients may be as high as ten. The aim of this study was to compare drug use in newly admitted patients (AP) to a geriatric medical centre for long-term care (LTC) with that of institutionalised patients (IP) at the centre. A cross-sectional study was conducted, between January 2001 and December 2002, in 324 functionally dependent and cognitively impaired elderly patients (> or = 65 years of age), consisting of 167 IP (127 females, 40 males) staying at the centre for > or = 3 months and 157 (117 females, 40 males) consecutive new admissions for LTC. All patients underwent a comprehensive geriatric assessment, which included a structured medical history, history of drug use, physical examination and functional and cognitive examinations. Overall drug use, drug categories and the basis of use (regular and/or as needed) were compared between the two groups of patients. The pattern of dru...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Aug 1, 1991·Journal of the American Geriatrics Society·D E EverittJ Avorn
Jan 1, 1990·International Psychogeriatrics·B W RovnerM F Folstein
Nov 25, 1988·JAMA : the Journal of the American Medical Association·M BeersS Salem
Apr 1, 1989·Journal of the American Geriatrics Society·R S BeardsleyD B Kamerow
Jan 1, 1987·Journal of the American Geriatrics Society·D K HellingJ Cornoni-Huntley
Aug 1, 1985·The American Journal of Medicine·K Kroenke
Aug 1, 1995·Annals of Internal Medicine·J Avorn, J H Gurwitz
Jul 17, 1995·The Medical Journal of Australia·J SnowdonP Tremlett
Jun 1, 1996·The Annals of Pharmacotherapy·H C LassilaD A Echement
Feb 1, 1997·Journal of the American Geriatrics Society·G P StoehrS Belle
Jul 29, 1998·European Journal of Clinical Pharmacology·L BjerrumJ Kragstrup
Nov 21, 1998·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Z FuchsB Modan
Aug 24, 1999·European Journal of Clinical Pharmacology·H F ThomasD K Luscombe
Feb 9, 2000·European Journal of Clinical Pharmacology·K N van DijkL T de Jong-van den Berg
Oct 26, 2000·European Journal of Clinical Pharmacology·I BaratE M Damsgaard
Apr 13, 2001·Journal of the American Geriatrics Society·M S GironJ Fastbom
Sep 28, 2001·The Annals of Pharmacotherapy·T JörgensenK Svärdsudd
Oct 18, 2002·Journal of Clinical Epidemiology·Tarja LinjakumpuRaimo Isoaho
Apr 24, 2003·The Annals of Pharmacotherapy·Jean-Blaise WasserfallenThierry Buclin
Sep 21, 1963·JAMA : the Journal of the American Medical Association·S KATZM W JAFFE
Jan 8, 2004·Mayo Clinic Proceedings·Darryl S ChutkaRobert W Hoel
Feb 3, 2005·British Medical Bulletin·Graham Ellis, Peter Langhorne
Oct 8, 2005·The American Journal of Clinical Nutrition·Nadya KaganskyShmuel Levy
Mar 29, 2008·Clinical Drug Investigation·C B Claesson, I K Schmidt

❮ Previous
Next ❯

Citations

Nov 20, 2012·Journal of Nutrition in Gerontology and Geriatrics·Roschelle Heuberger
Nov 20, 2012·Journal of the American Medical Directors Association·Philippe CestacYves Rolland
Apr 17, 2012·Clinics in Geriatric Medicine·Bruce K TamuraKamal H Masaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.